David A. Metcalfe - 25 Apr 2022 Form 4 Insider Report for NEXTGEN HEALTHCARE, INC.

Role
Chief Technology Officer
Signature
/s/ Jeffrey D. Linton, Attorney-in-Fact for David A. Metcalfe
Issuer symbol
N/A
Transactions as of
25 Apr 2022
Net transactions value
-$200,118
Form type
4
Filing time
26 Apr 2022, 16:52:03 UTC
Previous filing
28 Dec 2021
Next filing
04 May 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NXGN Common Stock Options Exercise $480,500 +33,838 +22% $14.20 188,851 25 Apr 2022 Direct F1
transaction NXGN Common Stock Sale $680,618 -33,838 -18% $20.11 155,013 25 Apr 2022 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NXGN Stock Option (right to buy) Options Exercise $0 -33,838 -17% $0.000000 166,162 25 Apr 2022 Common Stock 33,838 $14.20 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Pursuant to a 10b5-1(c) plan adopted by the reporting person on March 15, 2022.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.00 to $20.22. Full information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or its stockholders upon request.
F3 Original grant of 200,000 options granted on 2/1/2016 vested in four equal, annual installments beginning 2/1/2017.